These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6152031)

  • 21. Interhemispheric EEG coherence in never-medicated patients with paranoid schizophrenia: analysis at rest and during photic stimulation.
    Wada Y; Nanbu Y; Jiang ZY; Koshino Y; Hashimoto T
    Clin Electroencephalogr; 1998 Oct; 29(4):170-6. PubMed ID: 9783090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacoencephalography: current knowledge and prospects].
    Szelenberger W
    Psychiatr Pol; 1990; 24(6):52-7. PubMed ID: 2131484
    [No Abstract]   [Full Text] [Related]  

  • 23. Psychologists and psychoactive drugs.
    Murray JB
    Genet Psychol Monogr; 1978 Nov; 98(Second Half):281-323. PubMed ID: 31317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Benzamides, a therapeutic response adapted to 2 sides, paranoid and hebephrenic, of schizophrenia].
    Cassan P
    Ann Med Psychol (Paris); 1985 Jul; 143(7):677-82. PubMed ID: 2870674
    [No Abstract]   [Full Text] [Related]  

  • 25. Native EEG and treatment effects in neuroleptic-naïve schizophrenic patients: time and frequency domain approaches.
    Kikuchi M; Koenig T; Wada Y; Higashima M; Koshino Y; Strik W; Dierks T
    Schizophr Res; 2007 Dec; 97(1-3):163-72. PubMed ID: 17703921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [EEG frequency and regional properties in patients with paranoid schizophrenia: effects of positive and negative symptomatology prevalence].
    Bochkarev VK; Kirenskaya AV; Tkachenko AA; Samylkin DV; Novototsky-Vlasov VY; Kovaleva ME
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):66-74. PubMed ID: 25909792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Average reference EEG lateralization in schizophrenic patients.
    Merrin EL; Floyd TC
    J Neuropsychiatry Clin Neurosci; 1991; 3(3):307-14. PubMed ID: 1687964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of quantitative electroencephalography in psychiatry].
    Etevenon P; Péron-Magnan P
    Sem Hop; 1982 Dec; 58(44):2606-14. PubMed ID: 6297054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugs.
    Saletu B; Anderer P; Saletu-Zyhlarz GM
    Clin EEG Neurosci; 2006 Apr; 37(2):66-80. PubMed ID: 16733939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamical aspects of the EEG in different psychopathological states in an interview situation: a pilot study.
    Rockstroh B; Watzl H; Kowalik ZJ; Cohen R; Sterr A; Müller M; Elbert T
    Schizophr Res; 1997 Nov; 28(1):77-85. PubMed ID: 9428066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switch to ziprazidone treatment is associated with changes in MMN amplitude: a case report.
    Salazar J; Ordoño F; Soriano S; Rueda M; Ojeda E; Cozar R; Belloch V
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):573-4. PubMed ID: 19439243
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of therapeutically resistant paranoid schizophrenic patients with Moditen-depot combined with other psychotropic drugs and Leponex].
    Gamburg AL; Aranovich AG; Kotel'kevich IuN; Omorokov BM; Rasniuk VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(8):1211-6. PubMed ID: 6111169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproate as psychotropic agent. Interactions and adverse cerebral reactions.
    van Sweden B; van Moffaert M
    Acta Psychiatr Scand; 1985 Sep; 72(3):315-7. PubMed ID: 2866665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychocutaneous drug therapy.
    Lee CS; Koo J
    Semin Cutan Med Surg; 2003 Sep; 22(3):222-33. PubMed ID: 14649589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The atypical antipsychotic class of psychotropic agents. Foreword.
    McIntyre RS
    Expert Opin Pharmacother; 2012 Aug; 13(11):i-ii. PubMed ID: 22774778
    [No Abstract]   [Full Text] [Related]  

  • 36. [Electroencephalographic profile and dynamics of individual changes in the EEG of paranoid schizophrenics during treatment with aminazine (clinico-electroencephalographic correlation)].
    Bochkarov VK; Nikiforov AI; Tsirkin SIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1192-9. PubMed ID: 7315055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Psychotropic drugs].
    Müller-Spahn F
    Ther Umsch; 1999 Dec; 56(12):719-25. PubMed ID: 10638279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [OLFACTORY EEG PATTERNS OF MENTAL AND BEHAVIORAL DISORDERS DUE TO PSYCHOACTIVE SUBSTANCE USE].
    Bokhan NA; Masterova EI; Nevidimova TI; Savochkina DN
    Ross Fiziol Zh Im I M Sechenova; 2016 Oct; 102(10):1246-52. PubMed ID: 30193442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs in psychiatry.
    Aslam M; Stockley IH
    Nurs Times; 1979 Sep; 75(36):1539-44. PubMed ID: 38442
    [No Abstract]   [Full Text] [Related]  

  • 40. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.